Professor Kenyon is a midwife by background and a maternity researcher and policy maker. She currently leads a varied programme of applied health research.
This includes leading the maternity component of the Maternity and Child Health Theme for the CLAHRC West Midlands where there is involvement in service change at every level, from evaluating services in existence to developing and evaluating new services and translating evidence into practice. Methodologies employed ensure the most robust possible design and are tailored to the topic concerned and the timelines required.
Professor Kenyon is also the Chief Investigator for the HOLDS trial (High or Low Dose Syntocinon) which is funded by the NIHR HTA. This multicentre trial will provide robust evidence about the optimal dose regimen of Syntocinon (oxytocin) for nulliparous women with confirmed delay in the first stage of labour.
Professor Kenyon’s national roles include being part of the MBRRACE collaboration investigating maternal deaths, stillbirths and infant deaths, including the Confidential Enquiry into Maternal Perinatal Deaths. She is also a member of the Wellbeing of Women Advisory Committee and of the HTA Topic Identification, Development and Evaluation (TIDE) panel for Maternal, Neonatal and Child Health. HTA TIDE panel. She regularly speaks at conferences and has published widely.
She is an NIHR Midwifery Advocate for Career Development and usually has two midwives undertaking their MRes dissertations under her supervision, as well as a PhD student who is developing a patient reported outcome measure for pregnancy and childbirth.
Professor Kenyon is an Honorary Research Fellow at the Murdoch Children’s Research Institute (MCRI), University of Melbourne.
She has lead a Global Alignment of Immunisation safety Assessment in pregnancy (GAIA) consensus group for the Brighton Collaboration which is the world’s largest network of vaccine safety professionals agreeing the definition of dysfunctional labour.